Alpine Woods Capital Investors’s Pfizer PFE Stock Holding History

Alpine Woods Capital Investors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-105,827	Closed	-$2.71M	–	183
2024 Q1	$2.71M	Sell	105,827 -356	-0.3%	-$9.88K	0.54%	62
2023 Q4	$3.06M	Sell	106,183 -41,479	-28%	-$1.25M	0.46%	68
2023 Q3	$4.9M	Buy	147,662 +72	+0%	+$2.55K	0.79%	48
2023 Q2	$5.41M	Buy	147,590 +74,675	+102%	+$2.91M	0.85%	48
2023 Q1	$2.98M	Buy	72,915 +56,360	+340%	+$2.43M	0.45%	75
2022 Q4	$848K	Hold	16,555	–	–	0.12%	121
2022 Q3	$724K	Hold	16,555	–	–	0.1%	140
2022 Q2	$868K	Hold	16,555	–	–	0.11%	138
2022 Q1	$857K	Hold	16,555	–	–	0.09%	149
2021 Q4	$978K	Hold	16,555	–	–	0.1%	145
2021 Q3	$712K	Hold	16,555	–	–	0.08%	162
2021 Q2	$648K	Hold	16,555	–	–	0.07%	170
2021 Q1	$600K	Sell	16,555 -373	-2%	-$13.2K	0.07%	177
2020 Q4	$623K	Sell	16,928 -10,279	-38%	-$377K	0.08%	171
2020 Q3	$947K	Buy	27,207 +3,794	+16%	+$133K	0.14%	153
2020 Q2	$726K	Hold	23,413	–	–	0.14%	153
2020 Q1	$725K	Hold	23,413	–	–	0.16%	130
2019 Q4	$870K	Hold	23,413	–	–	0.17%	121
2019 Q3	$798K	Hold	23,413	–	–	0.15%	124
2019 Q2	$962K	Hold	23,413	–	–	0.2%	118
2019 Q1	$943K	Hold	23,413	–	–	0.21%	116
2018 Q4	$970K	Hold	23,413	–	–	0.23%	101
2018 Q3	$979K	Hold	23,413	–	–	0.2%	106
2018 Q2	$806K	Sell	23,413 -329,164	-93%	-$11.2M	0.18%	114
2018 Q1	$11.9M	Hold	352,577	–	–	0.63%	61
2017 Q4	$12.1M	Hold	352,577	–	–	0.61%	58
2017 Q3	$11.9M	Hold	352,577	–	–	0.61%	59
2017 Q2	$11.2M	Hold	352,577	–	–	0.6%	59
2017 Q1	$11.4M	Sell	352,577 -282	-0.1%	-$8.89K	0.61%	56
2016 Q4	$10.9M	Buy	352,859 +12,753	+4%	+$389K	0.6%	58
2016 Q3	$10.9M	Sell	340,106 -6,324	-2%	-$211K	0.6%	57
2016 Q2	$11.6M	Sell	346,430 -14,861	-4%	-$474K	0.69%	50
2016 Q1	$10.2M	Buy	361,291 +4,404	+1%	+$126K	0.59%	58
2015 Q4	$10.9M	Buy	356,887 +277,940	+352%	+$8.74M	0.59%	55
2015 Q3	$2.35M	Buy	78,947 +2,951	+4%	+$94.6K	0.13%	168
2015 Q2	$2.42M	Buy	75,996 +8,352	+12%	+$272K	0.12%	168
2015 Q1	$2.23M	Hold	67,644	–	–	0.11%	178
2014 Q4	$2M	Hold	67,644	–	–	0.1%	186
2014 Q3	$1.9M	Sell	67,644 -482,628	-88%	-$13.5M	0.1%	181
2014 Q2	$15.5K	Buy	550,272 +28,458	+5%	+$811K	0.4%	45
2014 Q1	$15.9M	Sell	521,814 -1,170	-0.2%	-$34.9K	0.88%	38
2013 Q4	$15.2M	Sell	522,984 -7,484	-1%	-$218K	0.87%	39
2013 Q3	$14.5M	Hold	530,468	–	–	0.89%	38
2013 Q2	$14.1M	Buy	+530,468	New	+$14.7M	0.9%	46

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Alpine Woods Capital Investors's PFE Position: Q2 2024 in Review

Alpine Woods Capital Investors sold out of Pfizer (PFE) in Q2 2024, closing a stake of 105,827 shares — an estimated $2.71M sold.

Alpine Woods Capital Investors first reported a position in PFE in Q2 2013 and held it in 44 quarters. The position peaked at $15.9M in Q1 2014. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

Alpine Woods Capital Investors reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
Alpine Woods Capital Investors sold 105,827 Pfizer shares in Q2 2024, an estimated $2.71M.
Alpine Woods Capital Investors first reported a position in Pfizer in Q2 2013 and held it in 44 quarters.
Alpine Woods Capital Investors's Pfizer position peaked at $15.9M in Q1 2014.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2024, filed 6 Aug 2024.